James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Williams Partners LP (WPZ), Alcoa Inc. (AA) and Ambarella Inc. (AMBA) Are 3 of Today’s Worst Stocks

Williams Partners (WPZ), Alcoa (AA) and Ambarella (AMBA) were left out of Monday's bullish festivities. Here's why.

10 Stocks to Buy: The Ultimate Set-It-and-Forget-It Portfolio

The market's best stocks to buy can come from any sector, and use any business model. What matters most is a perpetually marketable product.

Why Hershey Co. (HSY), Finisar Corporation (FNSR) and Vale SA (VALE) Are 3 of Today’s Worst Stocks

Hershey (HSY), Finisar (FNSR) and Vale (VALE) used more than their fair share of red ink on Friday. Here's what happened.

3 Rebound Stocks to Buy for Q3

Add Xerox (XRX), First Solar (FSLR) and Western Digital (WDC) to your list of surprising stocks to buy this summer.

Why Axovant Sciences Ltd (AXON), Oracle Corporation (ORCL) and Rite Aid Corporation (RAD) Are 3 of Today’s Worst Stocks

Thursday's huge rally didn't help Oracle (ORCL), Axovant Sciences (AXON) or Rite Aid (RAD) one iota. Here's what happened.